Ginkgo Bioworks

GPT-5 lowers the cost of cell-free protein synthesis

An autonomous laboratory system integrating OpenAI's GPT-5 with Ginkgo Bioworks' cloud automation platform achieved a 40% reduction in cell-free protein synthesis costs. The system operates via closed-loop experimentation, where the AI model iteratively designs, executes, and refines biological experiments without human intervention. This represents a concrete application of frontier LLMs to wet-lab automation and cost optimization in synthetic biology.